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Background: Dose calculations in intraoperative electron radiation therapy (IOERT) rely on the conventional
assumption of water-equivalent tissues at the applicator end, which defines a flat irradiation surface. However, the
shape of the irradiation surface modifies the dose distribution. Our study explores, for the first time, the use of
surface scanning methods for three-dimensional dose calculation of IOERT.
Methods: Two different three-dimensional scanning technologies were evaluated in a simulated IOERT
scenario: a tracked conoscopic holography sensor (ConoProbe) and a structured-light three-dimensional
scanner (Artec). Dose distributions obtained from computed tomography studies of the surgical field (gold
standard) were compared with those calculated under the conventional assumption or from pseudo-
computed tomography studies based on surfaces.
Results: In the simulated IOERT scenario, the conventional assumption led to an average gamma pass
rate of 39.9% for dose values greater than 10% (two configurations, with and without blood in the surgical
field). Results improved when considering surfaces in the dose calculation (88.5% for ConoProbe and 92.9%
for Artec).
Conclusions: More accurate three-dimensional dose distributions were obtained when considering surfaces in
the dose calculation of the simulated surgical field. The structured-light three-dimensional scanner provided
the best results in terms of dose distributions. The findings obtained in this specific experimental setup
warrant further research on surface scanning in the IOERT context owing to the clinical interest of improving
the documentation of the actual IOERT scenario.
Keywords: IOERT, Intraoperative radiotherapy, Surface scanning, Conoscopic holography, Structured-light 3D
scanner, Dose distributionBackground
Intraoperative electron radiation therapy (IOERT) refers
to the delivery of a single-fraction, high-energy electron
beam during surgery with the goal of promoting local
cancer control [1–3]. The target volume (namely a
post-resection tumour bed or the macroscopic residue
after partial resection) is irradiated by using a specific
applicator that pushes aside healthy tissues and collimates
the electron beam generated by a linear accelerator
(LINAC) [1, 4, 5].* Correspondence: vgarcia@hggm.es
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(http://creativecommons.org/publicdomain/zeIOERT dosimetry relies on the conventional as-
sumption of water-equivalent tissues in both stopping
and scattering power at the applicator end, which de-
fines a flat irradiation surface. Previous literature re-
ported small differences between prescribed doses
under previous assumption and measured doses using
in-vivo dosimetry in the case of breast IOERT scenar-
ios [6, 7]. However, Costa et al. [8], by placing radio-
chromic films on irradiation surfaces, showed that
clinical two-dimensional (2D) dose distributions in
pelvic IOERT scenarios frequently differ from the ex-
pected ones. In a previous study, Costa et al. [9] sim-
ulated these IOERT scenarios with solid water slabs
and a radiotherapy bolus, highlighting that the shapele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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surfaces) modified the dose distribution. Documenta-
tion of the actual scenario is relevant to the quality
assurance of IOERT and the proper assessment of
clinical results. However, the applicator position, the
angle of beam incidence in relation to the patient’s
anatomy and the shape of the irradiation surface are
not available in IOERT records. Intraoperative com-
puted tomography (CT) studies with the applicator
placed on the tumour bed would allow the calculation
of three-dimensional (3D) dose distributions of the
actual scenario before irradiation since these images
include tissue heterogeneities, surface irregularities of
the irradiated volume and the air gap from the appli-
cator end to the tumour bed. A portable CT scanner
inside the operating room or a LINAC with on-board
kV cone beam CT may be used for that purpose [10].
However, a low number of IOERT interventions per
week may not support the installation costs of
in-room imaging devices [11]. In addition, intraopera-
tive CT studies with metal artefacts (for example,
owing to shielding discs and surgical retractors) can-
not be directly used for dose calculation since CT
values are substantially altered.
An intermediate approach between the IOERT con-
ventional assumption and the use of intraoperative
CT images would involve 3D scanning the surface of
the tumour bed and the inclusion of these data in the
dose calculation. In a preliminary study [12], the au-
thors evaluated four different technologies to scan
surfaces, selecting a custom-made structured-light 3D
scanner as the most appropriate for IOERT in terms
of resolution, accuracy, acquisition time and cost.
However, this statement was based on scanning a half
body mannequin, not simulating an actual IOERT sce-
nario and calculating dose distributions. Brudfors et al.
[13] presented an open-source software for scanning sur-
faces with a tracked conoscopic holography sensor that
could also be used in IOERT. This system has been previ-
ously evaluated for clinical usage (for example, to scan hu-
man cadaver kidneys [14, 15] and resection cavities during
neurosurgeries [16]).
In this study we aimed to explore, for the first time, the
use of surface scanning methods for 3D dose calculation in
IOERT. Two different 3D scanning technologies were eval-
uated in a simulated IOERT scenario, a tracked conoscopic
holography sensor and a structured-light 3D scanner.
Methods
In this section, we describe the 3D scanning systems
assessed (section “3D scanning systems”), the process of cre-
ating 3D images from surfaces (section “Surface to pseu-
do-CT study for IOERT dose calculation”) and the
experiment designed to evaluate these non-contact devicesfor 3D dose calculation in IOERT (section “Experiment”). A
simulated surgical field was scanned with both 3D scanning
systems. 3D dose distributions obtained from CT studies of
the surgical field (gold standard) were compared with those
calculated under the conventional assumption of water-
equivalent tissues at the applicator end and with those
calculated from pseudo-CT studies based on surfaces.
3D scanning systems
Tracked conoscopic holography sensor
A conoscopic holography sensor measures distances to
objects with an interferometric technique based on the
double refraction of uniaxial crystals [17]. The collinear-
ity between the laser beam emitted and the cone of light
returned from the scanned object enables measurements
of sharp edges and inside narrow cavities. Distances are
converted into 3D coordinates of the scanned surface by
tracking the sensor [14].
The configuration selected in this study was that
presented in [13]: a ConoProbe Mark 10 sensor (Optimet,
Optical Metrology Ltd) (working distance from 155mm to
336mm with the 250-mm objective lens as the origin, laser
wavelength 655 nm, laser spot size 107 μm, laser power
lower than 1mW and weight 0.72 kg [18]) was tracked
by a multi-camera optical tracking system OptiTrack
(NaturalPoint, Inc.) with three optical cameras
FLEX:V100R2 (data rate 50 Hz).
The data acquired with the tracked ConoProbe sensor
(abbreviated hereafter to “ConoProbe”) is an unorganised
point set that is converted to a triangle mesh by calculating
its oriented surface normals and applying Poisson surface
reconstruction [19] by means of open-source software
MeshLab [20].
Structured-light 3D scanner
This 3D scanning technology is based on an incoherent
light source that projects structured 2D patterns onto the
scanned object, and a camera at a different viewpoint that
records the patterns geometrically distorted by the object
surface.
The specifications of the handheld 3D scanner selected
in this study, Artec Eva (abbreviated hereafter to
“Artec”), are: 3D resolution up to 0.5 mm, working dis-
tance from 0.4 m to 1 m, frame rate up to 16 fps and
weight 0.85 kg [21]. This solution includes another cam-
era to capture colour texture. The software Artec Studio
10 manages the capturing process, data post-processing,
3D model (triangle mesh) creation and texture mapping.
Surface to pseudo-CT study for IOERT dose calculation
Dose distributions are calculated with a treatment
planning system (TPS) specifically developed for
IOERT (radiance, GMV) [22, 23] based on a Monte
Carlo algorithm that takes account of the LINAC
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obtained from CT studies after converting Hounsfield
units (HU) values to physical density [10, 25]).
3D surfaces are converted into pseudo-CT studies for
dose calculation. In this process (Fig. 1), we first generate a
watertight surface by extruding a contour close to the mesh
edge (out of the surgical field) and covering the extra walls
generated with a lid (Autodesk software Meshmixer [26]
and Artec Studio 10). Second, the watertight surface is
converted to a 3D binary image by applying a ray intersec-
tion method [27] similar to that presented in [28]. Then,
this 3D image is transformed into a pseudo-CT study (de-
fined as a 3D image not acquired in a CT scanner but with
values in the HU scale) by setting the voxels above the
scanned surface to the CT value of air (− 1000 HU) and
the remaining voxels to water value (0 HU).Experiment
Experiment set-up
The experiment was carried out in a CT simulator room in
order to acquire reference CT studies. The cameras of the
optical tracking system were statically attached to three
STOLMEN posts (Inter IKEA Systems B.V.) around the table
of an Aquilion™ Large Bore CT simulator (Toshiba) (Fig. 2).
A surgical field was simulated with a large piece of
beef (weight 6 kg) placed at the bottom of a plastic box
(volume 28 × 39 × 57 cm), on the CT table, as shown inFig. 1 Conversion from 3D surface into pseudo-CT study. (a) 3D surface wi
generated after extruding the contour close to the mesh edge. (c) Green li
view of the 3D binary image generated after applying the ray intersection
limited to the boundaries of the watertight surface. (e) Axial view of the 3D
of the pseudo-CT study obtained by increasing the matrix size of the 3D b
and the remaining voxels to the CT value of water (orange colour in the pFig. 2. This large container simulated the volume of a
sterile field with surgical retractors that may hinder 3D
scanning. Six metallic nipple markers (diameter 1 mm,
SL-10, The Suremark Company) were placed on cuboids
of different heights around the phantom (Fig. 2). These
markers were used as landmarks for mapping surfaces
and CT studies into a common coordinate space.Acquisition protocol
The details of the acquisition protocol are as follows:
1. A CT study of the surgical field and the markers
(CTpreSurf or CT study acquired before surface
scanning) was acquired with the following
parameters: voltage 120 kVp, exposure 37 ± 10 mAs
(mean ± standard deviation), matrix size 512 ×
512 × 961 and voxel size 0.729 × 0.729 × 0.500 mm.
2. Laser beam (ConoProbe) sweeping of the surgical
field and the markers (Fig. 2, top right) (minimum
signal-to-noise ratio set to 40%).
3. Surface scanning of the surgical field and the markers





seudo-CSteps 2 and 3 were carried out from only one
viewpoint to simulate the difficulty of moving
around the patient in the operating room with our
wired 3D scanners connected to both the power
supply and the computer.en contour delineated close to the mesh edge. (b) Extra walls
ing those extra walls to obtain a watertight surface. (d) Axial
to the watertight surface. The matrix size of this 3D image is
image after correcting the region above the lid. (f) Axial view
age, and then by setting the black voxels to the CT value of air
T study)
Fig. 2 Experiment set-up. On the left, the CT simulator room with the multi-camera optical tracking system and the plastic box, which contained
the simulated surgical field and the markers, on the CT table. The three optical cameras of the tracking system were attached to three posts. On
the right, the simulated surgical field and the six markers placed at different heights. The configuration without blood is shown at the top right
while the configuration with blood is depicted at the bottom right
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of the patient table to obtain CTpostSurf (CT study
acquired after surface scanning), which was used to
check the stability of the whole setting (surgical
field and markers) by comparing CTpostSurf and
CTpreSurf. This verification was done because the
surface irregularities of the simulated surgical field
and the position of the markers could vary in steps
2 and 3 from the original setting shown in
CTpreSurf due to the force of gravity, the
movements of the CT table after CTpreSurf
acquisition or a wrong attachment of the markers.
The comparison was performed by superimposing
CTpostSurf to CTpreSurf and calculating the root-
mean-square error [RMSE] between the intensities
from both studies without applying any alignment.
5. Steps 1 through 4 were repeated after adding 40 ml
of pig blood with heparin (anticoagulant) to the
surgical field (Fig. 2, bottom right) in order to
simulate accumulation of biological fluid before
irradiation.
Surface registration
Scanned surfaces were mapped to CTpreSurf to set a
common coordinate space for comparisons in each
configuration (with and without blood). The trans-
formation matrix was calculated with a landmark
rigid registration algorithm based on singular value
decomposition [29] and the 3D coordinates of eachmarker (its centroid in the CT study and a point on
its 3D surface) using 3D Slicer software [30] and
SlicerIGT extension [31]. Colour texture (visible light
picture data from the surface) was essential for
obtaining the marker location in the Artec surfaces
since the markers were not properly identified in the
triangle meshes.
IOERT dose distributions
Registered surfaces were converted to pseudo-CT studies
of 1-mm isotropic voxel size by applying the method de-
scribed in section “Surface to pseudo-CT study for IOERT
dose calculation” (obtaining CTConoProbe and CTArtec
for ConoProbe and Artec surfaces respectively). CTpreSurf
studies were also resampled to that voxel size.
An IOERT case was simulated in the TPS by placing a
virtual applicator on CTpreSurf, CTConoProbe and
CTArtec (parameters: applicator diameter 70 mm, bevel
angle 30° and electron energy 9MeV). The following 3D
dose distributions were calculated for each configuration
(with and without blood) with a Monte Carlo algorithm
(error tolerance 1% [parameter that limits the maximum
estimated uncertainty of the simulated dose for doses
higher than 50% of the maximum dose] and resolution
1.0 mm) and the phase space of a conventional LINAC
(Varian 21EX):
 D_CTpreSurf (considered as the gold standard) was
calculated with CTpreSurf.
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Water option in the TPS to obtain the dose
distribution under the conventional assumption of
water-equivalent tissues at the applicator end. D_water
was obtained to assess the dose deviation when not in-
cluding tissue heterogeneities, surface irregularities of
the irradiated volume and the air gap from the applica-
tor end to the tumour bed in the dose calculation.
 D_CTtissue&air was calculated after converting
CTpreSurf to another pseudo-CT study (CTtissue&air)
that had only two different CT values (namely water
[0 HU] and air [− 1000 HU]). D_CTtissue&air was used
to assess the dose deviation when applying the same
simplification of CTConoProbe and CTArtec in the dose
calculation (namely not taking account of tissue hetero-
geneities but including surface irregularities of the irra-
diated volume and the air gap from the applicator end
to the tumour bed). CTtissue&air was obtained by first
segmenting the air in CTpreSurf using intensity thresh-
olding method (maximum limit − 500 HU), and then
setting those voxels to the CT value of air and the
remaining voxels (specifically, tissue) to the CT value of
water.
 D_CTConoProbe and D_CTArtec were calculated
with CTConoProbe and CTArtec respectively.
The output of the Monte Carlo algorithm was a 3D
dose distribution in percentage where 100% corre-
sponded to the maximum dose along the clinical axis
measured in a water phantom for the selected applicator
diameter and energy of the electron beam (in this study,
70 mm and 9MeV respectively), the bevel angle 0°, and
the source-to-surface distance set when conducting the
measurements for modelling the LINAC.
D_water, D_CTtissue&air, D_CTConoProbe and
D_CTArtec were compared with D_CTpreSurf using glo-
bal normalisation [32], and a 3D gamma criteria of
3%/3mm (thresholds accepted clinically) for dose values
greater than 10% or 70% (to focus on high-dose regions)
[10]. 3D gamma analyses did not take account of dose dif-





Generated 3D images CTpreSurf
CTtissue&air
CTConoProbe




aAcquisition protocol detailed in section “Acquisition protocol”
bStep detailed in section “Evaluation of 'Surface to pseudo-CT study' conversion proEvaluation of “Surface to pseudo-CT study” conversion
process
A source of error when using surface scanning
methods for 3D IOERT dose calculation is the conver-
sion from a 3D surface into a pseudo-CT study. The
surface created to assess this process was reproSurf,
which was created by first segmenting the voxels with
the CT value of water in CTtissue&air (configuration
without blood), then generating a watertight surface
(both steps done with 3D Slicer software), and finally
selecting a non-manifold surface of the surgical field
like that obtained with ConoProbe and Artec (step
done with Meshmixer software). The configuration
chosen was that without blood since its surface was
more irregular than that of the configuration with
blood. A pseudo-CT study (CTreproSurf ) was gener-
ated by applying the method detailed in section “Sur-
face to pseudo-CT study for IOERT dose calculation”
to reproSurf.
The evaluation consisted in comparing the 3D dose distri-
bution calculated with CTreproSurf (D_CTreproSurf) and
the reference 3D dose distribution D_CTtissue&air, which
was calculated with the CT study used to generate reproSurf.
CTreproSurf included both the error of generating the sur-
face from CTtissue&air and the error when converting that
surface into a pseudo-CT study. D_CTreproSurf was
obtained with the same IOERT parameters detailed in
section “IOERT dose distributions” and both dose dis-
tributions were compared using the same method de-
scribed in section “IOERT dose distributions”. This
comparison enabled us to assess the influence of the
conversion from a 3D surface into a pseudo-CT study
on the dose calculation.
Table 1 summarises the image studies and 3D dose
distributions previously explained in sections “Acquisi-
tion protocol”, “IOERT dose distributions” and “Evalu-
ation of 'Surface to pseudo-CT study' conversion
process”. Throughout the article, the prefix “CT” refers
to the CT/pseudo-CT study and the prefix “D_CT”
refers to the 3D dose distribution calculated from the






















































































































































































































































































































































































































































































































































García-Vázquez et al. Radiation Oncology          (2018) 13:243 Page 6 of 12
García-Vázquez et al. Radiation Oncology          (2018) 13:243 Page 7 of 12Results
Table 2 summarises the details of the surface scanning with
both devices. The laser power (ConoProbe) was manually
increased in the configuration with blood owing to the ab-
sorption of the red laser light. The scanning process of
both the surgical field and the markers with ConoProbe
took longer than with Artec, although the number of ver-
texes acquired with the latter was higher. Additional
post-processing of Artec data (namely removal of noisy
data, selection of surgical field and hole closing) was more
laborious than that for ConoProbe data (namely outlier re-
moval and selection of surgical field). The point-surface
error (PSE, root-mean-square distance between the
ConoProbe point set and its reconstructed surface) was
around 2 mm (Table 2). This difference was not calcu-
lated for Artec since its output was a triangle mesh, not
a point set.
In each configuration, CTpostSurf was superimposed to
CTpreSurf to check the stability of the whole setting (sur-
gical field and markers). Table 2 shows the RMSE between
both studies without applying any alignment. The RMSE
was lower than 26 HU in both configurations. In addition,
the only difference found when comparing CTpreSurf in
both configurations was the blood at the base of the
surgical field. The position and orientation difference
between the four CT studies was neglectable (lower than
0.30mm and 0.05° respectively). These values were
obtained from the transformation matrix calculated
when mapping CTpreSurf (configuration with blood)
and CTpostSurf (both configurations) to CTpreSurf
(configuration without blood) with the landmark rigid
registration algorithm explained in section “Surface
registration” and the 3D coordinates of the markers.
Table 2 shows the registration results between 3D sur-
faces and CTpreSurf. Target registration error (TRE,
root-mean-square distance between vertexes of each tri-
angle mesh and vertexes of the 3D surface obtained from
CTtissue&air) was lower than 1.9mm in all cases. Some
holes inside the surgical field did not perfectly match
when comparing CTtissue&air, and the pseudo-CT studies
CTConoProbe and CTArtec, as depicted in Fig. 3.
Figure 4 illustrates the complexity of the simulated
tumour bed and the IOERT scenario set in each configur-
ation. The maximum distance from the applicator end to
the surface of the simulated tumour bed was 33.5mm
(configuration without blood) and 13.2mm (configuration
with blood). Dose distributions are shown in Fig. 5 and
gamma pass rates are detailed in Table 3. D_CTtissue&air
closely followed D_CTpreSurf in both configurations
(average gamma pass rate 99.7% for dose values greater
than 10%) while D_water differed from D_CTpreSurf
(39.9%). A better dose agreement was found in the case of
D_CTConoProbe (88.5%) and D_CTArtec (92.9%). Figure 6
shows the gamma distribution for the dose distributionsevaluated to identify, in that axial view, where the gamma
criteria failed in the comparison for dose values greater
than 10%.
Figure 7 shows the agreement between the pseudo-CT
studies CTreproSurf and CTtissue&air. These studies were
used to assess the influence of the conversion from a 3D
surface into a pseudo-CT study on the dose calculation.
The percentage of voxels fulfilling the 3D gamma criteria
when comparing D_CTreproSurf with D_CTtissue&air
was 100.0% for dose values greater than 10% and for dose
values greater than 70%.
Discussion
Two different 3D scanning technologies were evaluated in
the context of 3D dose calculation in IOERT. Both devices
can scan at a distance greater than 30 cm (minimum safety
margin between unsterile personnel and the sterile field
[33]), suitable for the IOERT theatre. Advantages of Artec
over ConoProbe are a larger working distance (up to 1m)
and a shorter scanning time. Nevertheless, ConoProbe
can obtain better measurements inside narrow cavities
since its laser beam can access them more easily than the
structured 2D patterns generated by the Artec projector.
However, neither device could completely scan the deeper
hole of the simulated surgical field (Fig. 3, red arrows),
although ConoProbe was slightly better in this task.
CT studies (namely CTpreSurf and CTpostSurf ) were
used to check the stability of the whole setting (surgical
field and markers) and to obtain reference surfaces/stud-
ies and dose distributions. The results of the comparison
between CTpreSurf and CTpostSurf showed a similar
scenario in each configuration (with and without blood).
In addition, a similar IOERT case was simulated in both
configurations except for blood accumulation. The air
gap of the configuration without blood (maximum dis-
tance from the applicator end to the surface of the simu-
lated tumour bed 33.5 mm) was within the range seen in
limb sarcomas (air gaps up to 5 cm [34]). However, the
IOERT scenario simulated is not realistic for breast
IOERT, where the smoothness of the irradiation surface
and a minimum air gap from the applicator end to the
tumour bed can be ensured by other means [35].
The use of surface scanning for 3D dose calculation in
IOERT is based on assuming water-equivalent tissues at
the surface of the tumour bed, not at the applicator end
as in the conventional assumption. The gamma pass
rates obtained with D_CTtissue&air validated this as-
sumption for our experiment (average value 99.7% for
dose values greater than 10%) and therefore lower
gamma pass rates are due to surface defects in the
pseudo-CT studies. This statement may not be valid
when bone is included in the irradiation volume, as for
instance in a rectal cancer case where the tumour bed or
the high-risk area is very close to the sacrum.
Fig. 3 Comparison between CTtissue&air and the pseudo-CT studies CTConoProbe and CTArtec in both configurations (with and without blood). In
this figure, each pseudo-CT study (tissue depicted in orange colour) was superimposed on CTtissue&air (tissue represented in white colour). In all
cases, air was depicted in black colour. Therefore, tissue in the pseudo-CT study matches that in CTtissue&air when orange and white colours
overlap. On the other hand, air in the pseudo-CT study matches that in CTtissue&air when black colour is shown in the figure. Other options
represent mismatches. From left to right in each configuration, sagittal, coronal and axial views. The red arrows point to a deep hole not
completely scanned
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sumption of water-equivalent tissues at the applicator end
led to inaccurate dose distributions in both configurations
(average gamma pass rate 39.9% for dose values greater
than 10%). The configuration with blood presented a dif-
ferent surface of the simulated tumour bed (irradiation sur-
face flatter than that without blood) and a different air gap
compared with the configuration without blood. Results
improved when surfaces were considered in the dose cal-
culation although there were regions in the surgical field
that did not completely match, such as the 14-mm-widthFig. 4 IOERT scenario in both configurations (with and without blood). Virt
superimposed on CTpreSurf. This figure shows the surface irregularities of th
simulated tumour bed. From left to right, sagittal, coronal and axial views.hole in the configuration without blood (Fig. 3, axial view
of CTConoProbe and CTArtec). This hole could not be
properly scanned since a small piece of tissue protruded
and covered part of the hole. On the other hand, both de-
vices could scan a surgical field with blood.
The match between CTtissue&air and the pseudo-CT
studies CTConoProbe and CTArtec in the target volume
was better in the case of Artec compared with ConoProbe
(Fig. 3). Similarly, gamma pass rates with Artec were
better than those with ConoProbe (average values
92.9% and 88.5% for dose values greater than 10%ual applicator (grey cylinder with its contour in orange colour)
e irradiated volume and the air gap from the applicator end to the
H (head), F (feet), A (anterior), P (posterior), R (right) and L (left)
Fig. 5 3D dose distributions calculated using the Monte Carlo algorithm (axial view at the bevel centre). Virtual applicator represented as a grey
cylinder with its contour in orange colour. H (head), F (feet), A (anterior), P (posterior), R (right) and L (left)
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measurements were the surface reconstruction from
noisy points (PSE around 2 mm, Table 2) and larger
error in the location of the markers compared with
Artec (fiducial registration error [FRE] Table 2).Table 3 Percentage of voxels fulfilling the 3D gamma criteriaa








aDose matrices: 151 × 298 × 320. Voxel size 1.0 × 1.0 × 1.0 mm. Gamma pass rates ≥9
Average gamma pass rates for dose values greater than 10%: 39.9%, 99.7%, 88.5% andThe pseudo-CT study CTreproSurf fitted the CT study
used to generate reproSurf (namely CTtissue&air). These
CT studies were utilised to assess the influence of the con-
version from a 3D surface into a pseudo-CT study on the
dose calculation. The results showed that the influence3%/3mm









0% are highlighted in bold
92.9% for D_water, D_CTtissue&air, D_CTConoProbe and D_CTArtec respectively
Fig. 6 Gamma distributions superimposed on CTpreSurf (comparison for dose values greater than 10%). Gamma values lower or equal to 1 are
not shown. Same axial view showed as that in Fig. 5
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worst case of those presented in this study). Therefore, the
error in the dose distributions D_CTConoProbe and
D_CTArtec was caused by the inaccuracies of the scanned
surfaces, and the registration between the 3D surfaces and
CTpreSurf. 3D scanning from multiple viewpoints could
improve the acquired data and thus increase the gammaFig. 7 Comparison between CTtissue&air and the pseudo-CT study CTrepro
on CTtissue&air (tissue represented in white colour). In both cases, air was d
figure colours in Fig. 3pass rates, although it would further alter the surgical
workflow.
Other studies have proposed in-vivo dosimetry with
micro metal oxide semiconductor field-effect transistors,
radiochromic films or thermoluminescence radiation de-
tectors, which enables point and 2D dose measurements
in IOERT [8, 36, 37]. Our approach focuses only onSurf. CTreproSurf (tissue depicted in orange colour) was superimposed
epicted in black colour. More information on how to interpret the
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still be improved. Applicator position and angle of beam
incidence (applicator rotation) in relation to the patient’s
anatomy are required for dose calculations. After scan-
ning the surface of the tumour bed, the applicator pos-
ition and rotation could be collected with an optical
tracking system [38], and then combined with that
scanned surface to also obtain the air gap from the ap-
plicator end to the surface of the irradiated volume. The
applicator data would be in the same coordinate space
as the scanned surface when using ConoProbe (same op-
tical tracking system) while a calibration tool visible to
the tracking system and the Artec scanner should be
added to the scenario to map the applicator pose to the
scanned surface. Finally, it would be necessary to reduce
the data post-processing steps detailed in section “Surface
to pseudo-CT study for IOERT dose calculation” and
section “Results” in order to obtain a real-time implemen-
tation in the clinical practice, although this is not crucial
since the main interest was to obtain the actual dose dis-
tribution for quality assurance of IOERT, but not imme-
diately before irradiation.
Conclusions
This is the first study that explores the use of surface
scanning for 3D dose calculation in IOERT. In the simu-
lated IOERT scenario, the conventional assumption of
water-equivalent tissues at the applicator end led to
inaccurate dose distributions. More accurate dose distri-
butions were obtained when considering surfaces in the
dose calculation of our simulated surgical field. The
structured-light 3D scanner provided the best results in
terms of dose distributions. Surface scanning is a prom-
ising method that could be easily included in the clinical
practice, since the acquisition process is simple and does
not require much time, and the calculated dose is
comparable to the one that could be obtained with CT
imaging. The findings obtained in this specific experi-
mental setup warrant further research on surface scan-
ning in the IOERT context owing to the clinical interest
of improving the documentation of the actual IOERT
scenario.
Abbreviations
2D: Two-dimensional; 3D: Three-dimensional; CT: Computed tomography;
CTArtec: Pseudo-CT study obtained from Artec surface;
CTConoProbe: Pseudo-CT study obtained from ConoProbe surface;
CTpostSurf: CT study of the surgical field and the markers acquired after
surface scanning; CTpreSurf: CT study of the surgical field and the markers
acquired before surface scanning; CTreproSurf: Pseudo-CT study obtained
from reproSurf; CTtissue&air: Pseudo-CT study obtained after converting
CTpreSurf data to only two values, tissue and air; D_CTArtec: 3D dose
distribution calculated from CTArtec; D_CTConoProbe: 3D dose distribution
calculated from CTConoProbe; D_CTpreSurf: 3D dose distribution calculated
from CTpreSurf; D_CTreproSurf: 3D dose distribution calculated from
CTreproSurf; D_CTtissue&air: 3D dose distribution calculated from
CTtissue&air; D_water: 3D dose distribution calculated under the
conventional assumption of water-equivalent tissues at the applicator end;FRE: Fiducial registration error; HU: Hounsfield units; IOERT: Intraoperative
electron radiation therapy; LINAC: Linear accelerator; PSE: Point-surface error;
reproSurf: Surface generated from CTtissue&air; RMSE: Root-mean-square
error; TPS: Treatment planning system; TRE: Target registration error
Acknowledgements
The authors extend their gratitude to GMV SA (Madrid, Spain), Alexandra de
Francisco López, Yolanda Sierra Palomares, and medical physicists and
radiotherapy technicians at Hospital General Universitario Gregorio Marañón
(Madrid, Spain) for their valuable technical support.
Funding
This study was supported by Ministerio de Ciencia, Innovación y
Universidades [grant number TEC2013–48251-C2–1-R]; by Ministerio de
Ciencia, Innovación y Universidades, Instituto de Salud Carlos III and
European Regional Development Fund (FEDER) Funds from the European
Commission, “A way of making Europe” [grant numbers DTS14/00192, PI15/
02121]; and by Comunidad de Madrid [grant number TOPUS-CM S2013/MIT-
3024]. The CNIC is supported by the Ministerio de Ciencia, Innovación y
Universidades and the Pro CNIC Foundation, and is a Severo Ochoa Center
of Excellence (SEV-2015-0505).
Study sponsors had no involvement in the study design, in the collection,
analysis and interpretation of data; in the writing of the manuscript; and in
the decision to submit the manuscript for publication.
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
VGV, BSL, FAC and JP contributed in the study design. VGV and BSL
participated in data collection. VGV and BSL contributed to data analysis.
VGV, BSL, FAC, JJV, MD and JP provided data interpretation. VGV wrote the
draft manuscript. VGV, BSL, FAC, JJV, MD and JP revised the manuscript. JP
supervised this study. All authors read and approved the final manuscript.





The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Instituto de Investigación Sanitaria Gregorio Marañón. Calle Doctor
Esquerdo, 46, 28007, Madrid, Spain. 2Departamento de Oncología, Hospital
General Universitario Gregorio Marañón, Madrid, Spain. 3Facultad de
Medicina, Universidad Complutense de Madrid, Madrid, Spain. 4Clínica
Universidad de Navarra, Madrid, Spain. 5Departamento de Bioingeniería e
Ingeniería Aeroespacial, Universidad Carlos III de Madrid, Madrid, Spain.
6Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM),
Madrid, Spain. 7Centro Nacional de Investigaciones Cardiovasculares Carlos III
(CNIC), Madrid, Spain.
Received: 13 July 2018 Accepted: 12 November 2018
References
1. Calvo FA, Meirino RM, Orecchia R. Intraoperative radiation therapy – First
part: rationale and techniques. Crit Rev Oncol Hematol. 2006;59:106–15.
2. Nag S, Willett CG, Gunderson LL, Harrison LB, Calvo FA, Biggs P. IORT with
electron-beam, high-dose-rate brachytherapy or low-kV/electronic
brachytherapy: methodological comparisons. In: Gunderson LL, Willett CG,
Calvo FA, Harrison LB, editors. Intraoperative irradiation: techniques and
results. New York: Humana Press; 2011. p. 99–115.
García-Vázquez et al. Radiation Oncology          (2018) 13:243 Page 12 of 123. Calvo FA. Intraoperative irradiation: precision medicine for quality cancer
control promotion. Radiat Oncol. 2017;12:36.
4. Biggs P, Willett CG, Rutten H, Ciocca M, Gunderson LL, Calvo FA.
Intraoperative electron beam irradiation: physics and techniques. In:
Gunderson LL, Willett CG, Calvo FA, Harrison LB, editors. Intraoperative
irradiation: techniques and results. New York: Humana Press; 2011. p. 51–72.
5. Valentini V, Balducci M, Tortoreto F, Morganti AG, De Giorgi U, Fiorentini G.
Intraoperative radiotherapy: current thinking. Eur J Surg Oncol. 2002;28:180–5.
6. Ciocca M, Orecchia R, Garibaldi C, Rondi E, Luini A, Gatti G, et al. In vivo
dosimetry using radiochromic films during intraoperative electron beam
radiation therapy in early-stage breast cancer. Radiother Oncol. 2003;69:285–9.
7. Petoukhova A, Rüssel I, Nijst-Brouwers J, van Wingerden K, van Egmond J,
Jacobs D, et al. In vivo dosimetry with MOSFETs and GAFCHROMIC films
during electron IORT for accelerated partial breast irradiation. Phys Med.
2017;44:26–33.
8. Costa F, Sarmento S, Gomes D, Magalhães H, Arrais R, Moreira G, et al. In
vivo dosimetry using Gafchromic films during pelvic intraoperative electron
radiation therapy (IOERT). Br J Radiol. 2016;89:20160193.
9. Costa F, Sarmento S, Sousa O. Assessment of clinically relevant dose
distributions in pelvic IOERT using Gafchromic EBT3 films. Phys Med. 2015;
31:692–701.
10. García-Vázquez V, Marinetto E, Guerra P, Valdivieso-Casique MF, Calvo FÁ,
Alvarado-Vásquez E, et al. Assessment of intraoperative 3D imaging
alternatives for IOERT dose estimation. Z Med Phys. 2017;27:218–31.
11. Hensley FW. Present state and issues in IORT physics. Radiat Oncol.
2017;12:37.
12. Portalés C, Gimeno J, Vera L, Fernández M. Towards a guidance system to
aid in the dosimetry calculation of intraoperative electron radiation therapy.
J Imaging. 2015;1:180–92.
13. Brudfors M, García-Vázquez V, Sesé-Lucio B, Marinetto E, Desco M, Pascau J.
ConoSurf: open-source 3D scanning system based on a conoscopic
holography device for acquiring surgical surfaces. Int J Med Robot.
2017;13:e1788.
14. Burgner J, Simpson AL, Fitzpatrick JM, Lathrop RA, Herrell SD, Miga MI, et al.
A study on the theoretical and practical accuracy of conoscopic
holography-based surface measurements: toward image registration in
minimally invasive surgery. Int J Med Robot. 2013;9:190–203.
15. Simpson AL, Burgner J, Glisson CL, Herrell SD, Ma B, Pheiffer TS, et al.
Comparison study of intraoperative surface acquisition methods for surgical
navigation. IEEE Trans Biomed Eng. 2013;60:1090–9.
16. Simpson AL, Sun K, Pheiffer TS, Rucker DC, Sills AK, Thompson RC, et al.
Evaluation of conoscopic holography for estimating tumor resection cavities
in model-based image-guided neurosurgery. IEEE Trans Biomed Eng. 2014;
61:1833–43.
17. Álvarez I, Enguita JM, Frade M, Marina J, Ojea G. On-line metrology with
conoscopic holography: beyond triangulation. Sensors (Basel). 2009;9:7021–37.
18. OEM Manual for OPTIMET’S Mark10/10HD (P/N 3J06009, Rev 2): Optimet
Optical Metrology Ltd. http://www.optimet.com. Accessed 31 Nov 2017.
19. Kazhdan M, Bolitho M, Hoppe H. Poisson surface reconstruction. Symp
Geom Process. 2006:61–70.
20. Cignoni P, Callieri M, Corsini M, Dellepiane M, Ganovelli F, Ranzuglia G.
MeshLab: an open-source mesh processing tool. Sixth Eurographics Italian
Chapter Conference. 2008:129-36.
21. Professional 3D scanning solutions (Artec scanners brochure, 001-05/2017-
ENG): Artec 3D. https://www.artec3d.com. Accessed 31 Nov 2017.
22. Pascau J, Santos Miranda JA, Calvo FA, Bouché A, Morillo V, González-San
Segundo C, et al. An innovative tool for intraoperative electron beam
radiotherapy simulation and planning: description and initial evaluation by
radiation oncologists. Int J Radiat Oncol Biol Phys. 2012;83:e287–e95.
23. Valdivieso-Casique MF, Rodríguez R, Rodríguez-Bescós S, Lardíes D, Guerra P,
Ledesma MJ, et al. RADIANCE – a planning software for intra-operative
radiation therapy. Transl Cancer Res. 2015;4:196–209.
24. Herranz E, Herraiz JL, Ibáñez P, Pérez-Liva M, Puebla R, Cal-González J, et al.
Phase space determination from measured dose data for intraoperative
electron radiation therapy. Phys Med Biol. 2015;60:375–401.
25. Guerra P, Udías JM, Herranz E, Santos-Miranda JA, Herraiz JL, Valdivieso MF,
et al. Feasibility assessment of the interactive use of a Monte Carlo
algorithm in treatment planning for intraoperative electron radiation
therapy. Phys Med Biol. 2014;59:7159–79.
26. Autodesk Meshmixer. http://www.meshmixer.com. Accessed 31 Nov 2017.27. Aitkenhead AH. Mesh voxelisation. https://es.mathworks.com/matlabcentral/
fileexchange/27390-mesh-voxelisation. Accessed 1 Feb 2017.
28. Patil S, Ravi B. Voxel-based representation, display and thickness analysis of
intricate shapes. Proceedings of the 9th international conference on
computer aided design and. Computer Graphics. 2005.
29. Arun KS, Huang TS, Blostein SD. Least-squares fitting of two 3-D point sets.
IEEE Trans Pattern Anal Mach Intell. 1987;9:698–700.
30. Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S,
et al. 3D slicer as an image computing platform for the quantitative
imaging network. Magn Reson Imaging. 2012;30:1323–41.
31. Ungi T, Lasso A, Fichtinger G. Open-source platforms for navigated image-
guided interventions. Med Image Anal. 2016;33:181–6.
32. Bresciani S, Di Dia A, Maggio A, Cutaia C, Miranti A, Infusino E, et al.
Tomotherapy treatment plan quality assurance: the impact of applied
criteria on passing rate in gamma index method. Med Phys. 2013;40:121711.
33. Phillips N. Berry & Kohn's operating room technique. St. Louis: Elsevier
Health Sciences; 2016.
34. Soriani A, Iaccarino G, Felici G, Ciccotelli A, Pinnarò P, Giordano C, et al.
Development and optimization of a beam shaper device for a mobile
dedicated IOERT accelerator. Med Phys. 2012;39:6080–9.
35. Takanen S, Gambirasio A, Gritti G, Källi M, Andreoli S, Fortunato M, et al.
Breast cancer electron intraoperative radiotherapy: assessment of
preoperative selection factors from a retrospective analysis of 758 patients
and review of literature. Breast Cancer Res Treat. 2017;165:261–71.
36. Galimberti V, Ciocca M, Leonardi MC, Zanagnolo V, Paola B, Manuela S, et al.
Is electron beam intraoperative radiotherapy (ELIOT) safe in pregnant
women with early breast cancer? In vivo dosimetry to assess fetal dose. Ann
Surg Oncol. 2009;16:100–5.
37. López-Tarjuelo J, Bouché-Babiloni A, Morillo-Macías V, de Marco-Blancas N,
Santos-Serra A, Quirós-Higueras JD, et al. In vivo dosimetry in intraoperative
electron radiotherapy: microMOSFETs, radiochromic films and a general-
purpose linac. Strahlenther Onkol. 2014;190:1060–5.
38. García-Vázquez V, Marinetto E, Santos-Miranda JA, Calvo FA, Desco M,
Pascau J. Feasibility of integrating a multi-camera optical tracking system in
intra-operative electron radiation therapy scenarios. Phys Med Biol. 2013;58:
8769–82.
